WELCOME TO MEDSHADOW. WE'VE UPDATED OUR LOOK!

Quick Hits: Accutane, Acne Drug, Not Linked to Depression & More

Quick Hits
Quick Hits
Kimberly Bliss
Kimberly Bliss Culture Desk Editor
Last updated:

Accutane: Acne Drug Not Linked To Depression

A new study is throwing water on an argument made for years that the acne drug Accutane (isotretinoin) is linked to an increased risk of depression and mood disorders. Researchers conducted a retrospective study of 38,000 adults, all with an acne condition. About 1,000 were prescribed Accutane, and they took the drug, on average, for five months. An analysis found that 4% of Accutane patients developed depression, compared to 4% of those not taking the drug. Study author Bethanee Schlosser, MD, with Northwestern University Feinberg School of Medicine, told Healthday News that acne itself is associated with increased risk for mood changes, depression and low self-esteem. Posted March 4, 2019. Via HealthDay News.

How The FDA Plans To Combat Teen Tobacco and Vaping

The FDA has announced new steps it has taken in its effort to combat teen tobacco and vaping use. First, the agency has asked for a meeting with the manager of drugstore chain Walgreen Co. because of repeated violations of selling tobacco products to underage consumers. They found 22% of Walgreens stores that were inspected sold tobacco to underage patrons, the highest rate among drugstores. The FDA has also sent letters to more than 40 companies that may be marketing e-cigarette products illegally. The agency also sent out warning letters to several companies for selling electronic nicotine delivery system products and waterpipe tobacco products that didn’t include a required nicotine warning statement. Posted March 5, 2019. Via FDA.

Scott Gottlieb, FDA Commissioner, Resigning

FDA Commissioner Scott Gottlieb is resigning from his post within a month. His decision has surprised many as he is focused on several key initiatives, including lowering teen vaping rates, fighting the country’s opioid epidemic and speeding up drug approvals. Gottlieb said he was stepping down to spend more time with his wife and three children. A weekly commute from his home in Connecticut to Washington was also said to be a factor. There is no word yet on who might succeed Gottlieb. Posted March 5, 2019. Via FDA.

DISCLAIMER: MedShadow provides information and resources related to medications, their effects, and potential side effects. However, it is important to note that we are not a substitute for professional medical advice, diagnosis, or treatment. The content on our site is intended for educational and informational purposes only. Individuals dealing with medical conditions or symptoms should seek guidance from a licensed healthcare professional, such as a physician or pharmacist, who can provide personalized medical advice tailored to their specific circumstances.

While we strive to ensure the accuracy and reliability of the information presented on MedShadow, we cannot guarantee its completeness or suitability for any particular individual's medical needs. Therefore, we strongly encourage users to consult with qualified healthcare professionals regarding any health-related concerns or decisions. By accessing and using MedShadow, you acknowledge and agree that the information provided on the site is not a substitute for professional medical advice and that you should always consult with a qualified healthcare provider for any medical concerns.

Recommend More Articles Like This?

Culture Desk Editor
Show Comments (0)
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x